Chlorphenesin carbamate
Maolate (chlorphenesin carbamate) is a small molecule pharmaceutical. Chlorphenesin carbamate was first approved as Maolate on 1982-01-01. It is used to treat muscle cramp, muscle rigidity, myositis, pain, and spasm in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chlorphenesin carbamate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MAOLATE | Pamlab | N-014217 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
muscle cramp | HP_0003394 | D009120 | — |
muscle rigidity | HP_0002063 | D009127 | — |
myositis | EFO_0000783 | D009220 | G72.49 |
pain | EFO_0003843 | D010146 | R52 |
spasm | — | D013035 | M62.83 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | CHLORPHENESIN CARBAMATE |
INN | chlorphenesin |
Description | Chlorphenesin is glycerol in which the hydrogen of one of the primary hydroxy groups is substituted by a 4-chlorophenyl group. It has antifungal and antibacterial properties, and is used for treatment of cutaneous and vaginal infections. Its 1-carbamate is used as a skeletal muscle relaxant for the treatment of painful muscle spasm. It has a role as a muscle relaxant, an antibacterial drug and an antifungal drug. It is a glycol, a member of propane-1,2-diols and a member of monochlorobenzenes. |
Classification | Small molecule |
Drug class | tranquilizers/antiepileptics (propanediol and pentanediol groups) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NC(=O)OCC(O)COc1ccc(Cl)cc1 |
Identifiers
PDB | — |
CAS-ID | 104-29-0 |
RxCUI | 2399 |
ChEMBL ID | CHEMBL607710 |
ChEBI ID | 3643 |
PubChem CID | 7697 |
DrugBank | DB00856 |
UNII ID | I670DAL4SZ (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 134 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
3 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more